BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12855636)

  • 1. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
    Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B
    Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.
    Mosolits S; Markovic K; Fagerberg J; Frödin JE; Rezvany MR; Kiaii S; Mellstedt H; Jeddi-Tehrani M
    Cancer Immunol Immunother; 2005 Jun; 54(6):557-70. PubMed ID: 15570423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule.
    Ammons WS; Bauer RJ; Horwitz AH; Chen ZJ; Bautista E; Ruan HH; Abramova M; Scott KR; Dedrick RL
    Neoplasia; 2003; 5(2):146-54. PubMed ID: 12659687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.
    McLaughlin PM; Kroesen BJ; Dokter WH; van der Molen H; de Groot M; Brinker MG; Kok K; Ruiters MH; Buys CH; de Leij LF
    Cancer Immunol Immunother; 1999 Sep; 48(6):303-11. PubMed ID: 10473805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for EpCAM and Cytokeratin Expressing Epithelial Cells in Normal Human and Murine Blood and Bone Marrow.
    Holtorf SM; Boyle J; Morris R
    J Vis Exp; 2023 Apr; (194):. PubMed ID: 37154563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.
    Hu Y; Chen D; Napoleon JV; Srinivasarao M; Singhal S; Savran CA; Low PS
    Sci Rep; 2022 May; 12(1):8555. PubMed ID: 35595733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy.
    Carlson P; Dasgupta A; Grzelak CA; Kim J; Barrett A; Coleman IM; Shor RE; Goddard ET; Dai J; Schweitzer EM; Lim AR; Crist SB; Cheresh DA; Nelson PS; Hansen KC; Ghajar CM
    Nat Cell Biol; 2019 Feb; 21(2):238-250. PubMed ID: 30664790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.
    Agnoletto C; Minotti L; Brulle-Soumare L; Pasquali L; Galasso M; Corrà F; Baldassari F; Judde JG; Cairo S; Volinia S
    Biomark Res; 2018; 6():31. PubMed ID: 30450210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
    Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
    BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.
    Sawada T; Watanabe M; Fujimura Y; Yagishita S; Shimoyama T; Maeda Y; Kanda S; Yunokawa M; Tamura K; Tamura T; Minami H; Koh Y; Koizumi F
    Cancer Sci; 2016 Mar; 107(3):307-14. PubMed ID: 26708016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.
    Hardingham JE; Grover P; Winter M; Hewett PJ; Price TJ; Thierry B
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S25-31. PubMed ID: 26605644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
    Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP
    BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
    Massoner P; Thomm T; Mack B; Untergasser G; Martowicz A; Bobowski K; Klocker H; Gires O; Puhr M
    Br J Cancer; 2014 Aug; 111(5):955-64. PubMed ID: 24992580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
    Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
    Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strains.
    Wang H; Chen NG; Minev BR; Zimmermann M; Aguilar RJ; Zhang Q; Sturm JB; Fend F; Yu YA; Cappello J; Lauer UM; Szalay AA
    PLoS One; 2013; 8(9):e71105. PubMed ID: 24019862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells.
    Jain J; Veggiani G; Howarth M
    Cancer Res; 2013 Apr; 73(7):2310-21. PubMed ID: 23378340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.